| COPD and gender differences: an update S Aryal, E Diaz-Guzman, DM Mannino Translational Research 162 (4), 208-218, 2013 | 267 | 2013 |
| Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes S Aryal, E Diaz-Guzman, DM Mannino International journal of chronic obstructive pulmonary disease, 1145-1154, 2014 | 260 | 2014 |
| Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure CS King, D Sahjwani, AW Brown, S Feroz, P Cameron, E Osborn, ... Plos one 15 (11), e0242651, 2020 | 109 | 2020 |
| Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial FJ Martinez, E Yow, KR Flaherty, LD Snyder, MT Durheim, SR Wisniewski, ... Jama 325 (18), 1841-1851, 2021 | 62 | 2021 |
| Lung transplantation for patients with COVID-19 CS King, H Mannem, J Kukreja, S Aryal, D Tang, JP Singer, A Bharat, ... Chest 161 (1), 169-178, 2022 | 55 | 2022 |
| Single‐center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients S Aryal, SB Katugaha, A Cochrane, AW Brown, SD Nathan, OA Shlobin, ... Transplant Infectious Disease 21 (6), e13166, 2019 | 47 | 2019 |
| Fostamatinib for the treatment of hospitalized adults with coronavirus disease 2019: a randomized trial JR Strich, X Tian, M Samour, CS King, O Shlobin, R Reger, J Cohen, ... Clinical Infectious Diseases 75 (1), e491-e498, 2022 | 43 | 2022 |
| Occupational chronic obstructive pulmonary disease: an update E Diaz-Guzman, S Aryal, DM Mannino Clinics in chest medicine 33 (4), 625-636, 2012 | 40 | 2012 |
| Pulmonary complications of cystic fibrosis B Garcia, PA Flume Seminars in respiratory and critical care medicine 40 (06), 804-809, 2019 | 39 | 2019 |
| Critical care of the adult patient with cystic fibrosis CS King, AW Brown, S Aryal, K Ahmad, S Donaldson Chest 155 (1), 202-214, 2019 | 35 | 2019 |
| Prevalence of COPD and comorbidity S Aryal, E Diaz-Guzman, DM Mannino Eur Respir Monogr 59, 1-12, 2013 | 33 | 2013 |
| Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care M Keller, J Sun, C Mutebi, P Shah, D Levine, S Aryal, A Iacono, I Timofte, ... The Journal of Heart and Lung Transplantation 41 (4), 458-466, 2022 | 30 | 2022 |
| An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis S Aryal, SD Nathan Expert opinion on emerging drugs 23 (2), 159-172, 2018 | 25 | 2018 |
| Epidemiology of comorbidities in chronic obstructive pulmonary disease: clusters, phenotypes and outcomes S Aryal, E Diaz-Guzman, DM Mannino Italian Journal of Medicine 6 (4), 276-284, 2012 | 24 | 2012 |
| Surgical lung biopsy for interstitial lung disease. Safety and feasibility at a tertiary referral center J Pastre, S Khandhar, S Barnett, I Ksovreli, H Mani, AW Brown, ... Annals of the American Thoracic Society 18 (3), 460-467, 2021 | 23 | 2021 |
| Efzofitimod for the treatment of pulmonary sarcoidosis DA Culver, S Aryal, J Barney, CCW Hsia, WE James, LA Maier, LT Marts, ... Chest 163 (4), 881-890, 2023 | 22 | 2023 |
| Association between anticoagulation and survival in interstitial lung disease: an analysis of the pulmonary fibrosis foundation patient registry CS King, E Freiheit, AW Brown, OA Shlobin, S Aryal, K Ahmad, ... Chest 159 (4), 1507-1516, 2021 | 20 | 2021 |
| Single vs. bilateral lung transplantation: when and why S Aryal, SD Nathan Current Opinion in Organ Transplantation 23 (3), 316-323, 2018 | 20 | 2018 |
| Contemporary optimized practice in the management of pulmonary sarcoidosis S Aryal, SD Nathan Therapeutic advances in respiratory disease 13, 1753466619868935, 2019 | 19 | 2019 |
| HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines SD Nathan, J Pastre, I Ksovreli, S Barnett, C King, S Aryal, K Ahmad, ... Therapeutic advances in respiratory disease 14, 1753466620968496, 2020 | 17 | 2020 |
